Lakeshore Biopharma Co. Ltd (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | ||
| Net Income | -4,681 | 0 |
| Other Working Capital | 406 | 0 |
| Other Operating Activity | 4,637 | 0 |
| Operating Cash Flow | $362 | $0 |
| Cash Flows From Investing Activities | ||
| Other Investing Activity | -200,000 | 0 |
| Investing Cash Flow | $-200,000 | $0 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 196,000 | N/A |
| Other Financing Activity | 5,498 | 0 |
| Financing Cash Flow | $201,498 | $0 |
| End Cash Position | 1,860 | 0 |
| Net Cash Flow | $1,860 | $0 |
| Free Cash Flow | ||
| Operating Cash Flow | 362 | 0 |
| Free Cash Flow | 362 | 0 |